Chronic Hepatitis—A Perspective on Classification and Determinants of Prognosis

Gastroenterology

Volumn 70, Issue 6, 1976, Pages 1161-1171

  Boyer, James L ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC ACTIVE HEPATITIS; CHRONIC HEPATITIS; ETIOLOGY; HEPATITIS; HISTOLOGY; LIVER NECROSIS; REVIEW;

CHRONIC DISEASE; HEPATITIS; HEPATITIS, TOXIC; HUMAN; LIVER; LIVER CIRRHOSIS; NECROSIS; PROGNOSIS;

EID: 0017191116     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(76)80332-0     Document Type: Article

References (67)

1. Classification and treatment of chronic active liver disease
2. Chronic active liver disease re-examined: prognosis hopeful
3. Natural history of active chronic hepatitis. I. Clinical features, course, diagnostic criteria, morbidity, mortality and survival
4. Chronic hepatitis
5. Chronic hepatitis as a first manifestation of Wilson's disease
6. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis
7. ]Effect of prednisone on the survival of patients with cirrhosis of the liver. A report from the Copenhagen Study Group for Liver Diseases
8. Sex, ascites and alcoholism in survival of patients with cirrhosis. Effect of prednisone. A report from the Copenhagen Study Group for Liver Diseases
9. Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis
10. Chronic active liver disease-the range of histologic lesions, their response to treatment, and evolution
11. The fading menace of chronic hepatitis
12. Asymptomatic chronic hepatitis
13. A classification of chronic hepatitis
14. Liver disease in Australia-antigen-positive blood donors
15. Liver disease in asymptomatic carriers of hepatitis B antigen
16. Chronic liver disease in asymptomatic narcotic addicts
17. Subacute hepatic necrosis and postnecrotic cirrhosis due to anicteric infections with the hepatitis virus
18. Lupoid hepatitis: a comparison of 22 cases with other types of chronic liver disease
19. Active “juvenile” cirrhosis considered as part of a systemic disease and the effect of corticosteroid therapy
20. Active chronic hepatitis
21. Chronic viral hepatitis
22. Incidence and meaning of persistence of Australia antigen in patients with acute viral hepatitis: development of chronic hepatitis
23. Infectious hepatitis in Bristol 1959-1962
24. The treatment of acute infectious hepatitis-ten-year follow-up study of the effects of diet and rest
25. The incidence of residuals of viral hepatitis
26. Prevalence and nature of hepatic disturbance following acute viral hepatitis with jaun
27. Viral hepatitis, type A: Identification by specific complement fixation and immune adherance tests
28. Antigene Australia e epatite virale. Nota II. Presenza e comportamento dell antigene Australia in corso di epatopatie
29. Australia antigen in acute and chronic liver disease
30. SH antigen and chronic liver disease
31. L-antigene Australia in alcune epatopatie acute e chroniche
32. Australia antigen as a hepatitis virus: variation in host response
33. Australia antigen in active chronic hepatitis in Australia: results in 130 patients from three centers
34. Hepatitis associated antigen in chronic liver disease
35. Toxic and drug induced hepatitis
36. Drug induced hepatic injury
37. Aspirin-induced hepatotoxicity in patients with systemic lupus erythematosis
38. Aspirin hepatitis
39. Isoniazid hepatitis
40. Severe hepatitis from methyldopa
41. Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin
42. The problem of chronic liver disease in young women
43. Liver disease in young women with hyperglobulinemia
44. Lupoid hepatitis
45. Plasma-cell hepatitis, with special attention to steroid therapy
46. Waldenstrom's chronic active hepatitis
47. Prednisone for chronic active liver disease: dose titration, standard dose and combination with azathioprine compared
48. Multisystem involvement in chronic liver disease-studies on the incidence and pathogenesis
49. Association of autoimmune active chronic hepatitis with HL-Al, 8
50. Histocompatibility antigens in chronic hepatitis and primary biliary cirrhosis
51. Genetic analysis of patients with chronic active hepatitis
52. High prevalence of sero-immunologic abnormalities in relatives of patients with active chronic hepatitis or primary biliary cirrhosis
53. Hereditary hypergammaglobulinemia and lupoid hepatitis
54. Familial cirrhosis with autoimmune features and raised immunoglobulin levels
55. Immunopathogenesis of chronic hepatitis: a review
56. “Lupoid” hepatitis, a nonentity in the spectrum of chronic active liver disease
57. Cell-mediated immunity to Hepatitis B antigen in antigen-negative active chronic hepatitis
58. Inadequate antibody response to HBAg or suppressor T-cell defect in development of active chronic hepatitis
59. Mitochondrial antibodies and subclinical liver disease
60. Phenylbutazone hepatitis
61. Azathioprine therapy of “autoimmune” diseases
62. Pattern of necrosis in acute viral hepatitis-prognostic value of bridging (subacute hepatic necrosis)
63. Medical progress. Subacute hepatitis
64. The clinical and histologic spectrum of acute viral hepatitis
65. Prognostic significance of subacute hepatic necrosis in acute hepatitis
66. Prognosis of chronic persistent hepatitis
67. Initial morphologic appearances determine responses to treatment of chronic active liver disease (CALD): a prospective study (abstr)